129 related articles for article (PubMed ID: 37716239)
21. Positive prostate-specific antigen circulating cells detected by reverse transcriptase-polymerase chain reaction does not imply the presence of prostatic micrometastases.
Thiounn N; Saporta F; Flam TA; Pages F; Zerbib M; Vieillefond A; Martin E; Debré B; Chevillard S
Urology; 1997 Aug; 50(2):245-50. PubMed ID: 9255296
[TBL] [Abstract][Full Text] [Related]
22. Prostate-specific antigen: what's new in 1997.
Pannek J; Partin AW
Oncology (Williston Park); 1997 Sep; 11(9):1273-8; discussion 1279-82. PubMed ID: 9306417
[TBL] [Abstract][Full Text] [Related]
23. Detection of circulating prostate-specific antigen-positive cells in patients with prostate cancer by flow cytometry and reverse transcription polymerase chain reaction.
Fadlon EJ; Rees RC; McIntyre C; Sharrard RM; Lawry J; Hamdy FC
Br J Cancer; 1996 Aug; 74(3):400-5. PubMed ID: 8695355
[TBL] [Abstract][Full Text] [Related]
24. The combination of ovarian volume and outline has better diagnostic accuracy than prostate-specific antigen (PSA) concentrations in women with polycystic ovarian syndrome (PCOs).
Bili E; Dampala K; Iakovou I; Tsolakidis D; Giannakou A; Tarlatzis BC
Eur J Obstet Gynecol Reprod Biol; 2014 Aug; 179():32-5. PubMed ID: 24965976
[TBL] [Abstract][Full Text] [Related]
25. Serum Prostate-Specific Antigen Level in Women With Polycystic Ovary Syndrome: A Systematic Review and Meta-analysis.
Maleki-Hajiagha A; Razavi M; Rezaeinejad M; Sepidarkish M; Mehri A; Vesali S; Allameh Z
Horm Metab Res; 2019 Apr; 51(4):230-242. PubMed ID: 31022739
[TBL] [Abstract][Full Text] [Related]
26. Highly sensitive immunosensing of prostate-specific antigen based on ionic liquid-carbon nanotubes modified electrode: application as cancer biomarker for prostate biopsies.
Salimi A; Kavosi B; Fathi F; Hallaj R
Biosens Bioelectron; 2013 Apr; 42():439-46. PubMed ID: 23235113
[TBL] [Abstract][Full Text] [Related]
27. Detection of prostate-specific antigen- or prostate-specific membrane antigen-positive circulating cells in prostatic cancer patients: clinical implications.
Millon R; Jacqmin D; Muller D; Guillot J; Eber M; Abecassis J
Eur Urol; 1999 Oct; 36(4):278-85. PubMed ID: 10473985
[TBL] [Abstract][Full Text] [Related]
28. Beyond PSA: utility of novel tumor markers in the setting of elevated PSA.
Lin DW
Urol Oncol; 2009; 27(3):315-21. PubMed ID: 19414121
[TBL] [Abstract][Full Text] [Related]
29. Serum-to-urinary prostate-specific antigen ratio: a potential means of distinguishing benign prostatic hyperplasia from prostate cancer.
Irani J; Millet C; Levillain P; Doré B; Begon F; Aubert J
Eur Urol; 1996; 29(4):407-12. PubMed ID: 8791046
[TBL] [Abstract][Full Text] [Related]
30. Sandwich pair nanobodies, a potential tool for electrochemical immunosensing serum prostate-specific antigen with preferable specificity.
Liu X; Wang D; Chu J; Xu Y; Wang W
J Pharm Biomed Anal; 2018 Sep; 158():361-369. PubMed ID: 29935325
[TBL] [Abstract][Full Text] [Related]
31. Combined nested reverse transcription-PCR assay for prostate-specific antigen and prostate-specific membrane antigen in detecting circulating prostatic cells.
Zhang Y; Zippe CD; Van Lente F; Klein EA; Gupta MK
Clin Cancer Res; 1997 Jul; 3(7):1215-20. PubMed ID: 9815802
[TBL] [Abstract][Full Text] [Related]
32. Quantification of prostate specific antigen mRNA levels in circulation after prostatic surgery and endocrine treatment by quantitative reverse transcription-polymerase chain reaction.
Lintula S; Vesalainen S; Rannikko A; Zhang WM; Finne P; Stenman J; Stenman UH
Scand J Clin Lab Invest; 2004 Apr; 64(2):93-100. PubMed ID: 15115245
[TBL] [Abstract][Full Text] [Related]
33. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
34. Serum complexed and free prostate-specific antigen (PSA) for the diagnosis of the polycystic ovarian syndrome (PCOS).
Diamandis EP; Stanczyk FZ; Wheeler S; Mathew A; Stengelin M; Nikolenko G; Glezer EN; Brown MD; Zheng Y; Chen YH; Wu HL; Azziz R
Clin Chem Lab Med; 2017 Oct; 55(11):1789-1797. PubMed ID: 28361781
[TBL] [Abstract][Full Text] [Related]
35. Detection of prostate carcinoma using prostate specific antigen, its density, and the density of the transition zone in Japanese men with intermediate serum prostate specific antigen concentrations.
Gohji K; Nomi M; Egawa S; Morisue K; Takenaka A; Okamoto M; Ohori M; Fujii A
Cancer; 1997 May; 79(10):1969-76. PubMed ID: 9149025
[TBL] [Abstract][Full Text] [Related]
36. Molecular staging of prostate cancer: comparison of nested reverse transcription polymerase chain reaction assay using prostate specific antigen versus prostate specific membrane antigen as primer.
Okegawa T; Yoshioka J; Morita R; Nutahara K; Tsukada Y; Higashihara E
Int J Urol; 1998 Jul; 5(4):349-56. PubMed ID: 9712443
[TBL] [Abstract][Full Text] [Related]
37. Sensitive nested reverse transcription polymerase chain reaction detection of circulating prostatic tumor cells: comparison of prostate-specific membrane antigen and prostate-specific antigen-based assays.
Israeli RS; Miller WH; Su SL; Powell CT; Fair WR; Samadi DS; Huryk RF; DeBlasio A; Edwards ET; Wise GJ
Cancer Res; 1994 Dec; 54(24):6306-10. PubMed ID: 7527294
[TBL] [Abstract][Full Text] [Related]
38. Quantitative PSA RT-PCR for preoperative staging of prostate cancer.
Kurek R; Ylikoski A; Renneberg H; Konrad L; Aumüller G; Roddiger SJ; Zamboglou N; Tunn UW; Lilja H
Prostate; 2003 Sep; 56(4):263-9. PubMed ID: 12858354
[TBL] [Abstract][Full Text] [Related]
39. Serum prostate-specific antigen in a community-based population of healthy men. Establishment of age-specific reference ranges.
Oesterling JE; Jacobsen SJ; Chute CG; Guess HA; Girman CJ; Panser LA; Lieber MM
JAMA; 1993 Aug; 270(7):860-4. PubMed ID: 7688054
[TBL] [Abstract][Full Text] [Related]
40. Sample preparation of serum to allow capillary electrophoresis analysis of prostate specific antigen isoforms.
Farina-Gomez N; Barrabes S; Gomez-Lopez JE; Gonzalez M; Puerta A; Navarro-Calderon D; Albers-Acosta E; Olivier C; Diez-Masa JC; Peracaula R; de Frutos M
J Pharm Biomed Anal; 2017 Feb; 134():220-227. PubMed ID: 27918991
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
